|
JIN-A02 Clinical Trials
1 actively recruiting trial across 1 location
Orange, California1 trial
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
Chao Family Comprehensive Cancer Center, University of California Irvine Healthcare
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.